BIO-BBIO-BNYSE
Loading
Operating Income ContractionContracting
Percentile Rank43
3Y CAGR-22.0%
5Y CAGR-11.5%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
-22.0%/yr
Annual compound
5Y CAGR
-11.5%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$229.10M-14.8%
2024$269.00M-20.4%
2023$337.80M-30.0%
2022$482.62M-3.5%
2021$500.34M+18.8%
2020$421.33M+83.5%
2019$229.66M+311.4%
2018$-108.64M-193.1%
2017$116.65M+119.3%
2016$53.19M-